Author

D. B. Lewis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:plant (other)· 1

Frequent Co-Authors

A. Chemparathy· 1 shared C. Richards· 1 shared D. Endy· 1 shared F. Simonetta· 1 shared G. A. Fox· 1 shared G. Dhamdhere· 1 shared J. Baker· 1 shared J. Mounger· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Chemparathy

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Single-cell Transcriptomics Reveal Different Maturation Stages and Sublineages Commitment of Human Thymic Invariant Natural Killer T cells

K. Maas-Bauer, S. Acharya, J. Baker, D. B. Lewis, R. S. Negrin, F. Simonetta

This study uses single-cell RNA sequencing to identify maturation stages and sublineage commitment in human thymic iNKT cells, revealing two distinct clusters with immature and mature profiles.

bioRxiv · Aug 10, 2022Cell Biology

Response to nitrogen and salinity in Rhizophora mangle propagules varies by maternal family and population of origin

C. Richards, K. L. Langanke, J. Mounger, G. A. Fox, D. B. Lewis

This study examines how Rhizophora mangle propagules respond to salt and nitrogen levels, showing population-specific plasticity and survival differences.

bioRxiv · Aug 4, 2021Ecology

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza

T. R. Abbott, G. Dhamdhere, Y. Liu, X. Lin, L. E. Goudy, L. Zeng, A. Chemparathy, S. Chmura, N. Heaton, R. Debs, T. Pande, D. Endy, M. La Russa, D. B. Lewis, L. S. Qi

This paper develops a CRISPR-Cas13-based strategy called PAC-MAN to inhibit SARS-CoV-2 and influenza A virus in human cells, showing it can degrade viral sequences and reduce replication.

bioRxiv · Mar 13, 2020 · PreprintBioengineering